Connection
Kapil Yadav to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Kapil Yadav has written about Antibodies, Monoclonal, Humanized.
|
|
Connection Strength |
|
|
|
|
|
0.120 |
|
|
|
-
Yadav K, Sharma M, Ferdinand KC. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: Present perspectives and future horizons. Nutr Metab Cardiovasc Dis. 2016 10; 26(10):853-62.
Score: 0.120